➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Harvard Business School
McKinsey
Mallinckrodt
Merck

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: HEPARIN SODIUM


Email this page to a colleague

« Back to Dashboard

HEPARIN

CASRN: 9005-49-6

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Express Scripts
Medtronic
Boehringer Ingelheim
AstraZeneca